Substance Use Tools & Resources
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Opioid Risk Tool
Pain Assessment and Documentation Tool (PADT)
Facilitates ongoing evaluation of patient pain and documentation of pain management. Includes sections to assess pain-related outcomes in four areas: analgesia, activities of daily living, adverse events, and aberrant drug-related behavior.
Drug Use Disorders Identification Test
Screens individuals for drug dependence, including use of opioids, with an 11-item self-report instrument.
Long-Term Controlled Substances Therapy for Chronic Pain: Sample Agreement
Consent form on which patient agrees to follow policies related to long-term use of opioids because these drugs have potential for abuse or diversion.
McCaffrey Initial Pain Assessment Tool
Guides healthcare professionals through an initial assessment of patient pain. Includes diagrams of the human body to help patients locate the pain they experience, as well as questions to prompt the patient to describe the intensity, quality, causes, effects, and contributing factors of the pain.
Screening for Addiction in Patients With Chronic Pain and "Problematic" Substance Use: Evaluation of a Pilot Assessment Tool
Substance Abuse Subtle Screening Inventory (SASSI)
The SISAP: A New Screening Instrument for Identifying Potential Opioid Abusers in the Management of Chronic Nonmalignant Pain Within General Medical Practice
Severity of Dependence Scale
Provides a score indicating the severity of dependence on opioids using a 5-item questionnaire.